![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: C1D |
Gene summary for C1D |
![]() |
Gene information | Species | Human | Gene symbol | C1D | Gene ID | 10438 |
Gene name | C1D nuclear receptor corepressor | |
Gene Alias | LRP1 | |
Cytomap | 2p14 | |
Gene Type | protein-coding | GO ID | GO:0000460 | UniProtAcc | Q13901 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
10438 | C1D | P15T-E | Human | Esophagus | ESCC | 2.29e-61 | 1.36e+00 | 0.1149 |
10438 | C1D | P16T-E | Human | Esophagus | ESCC | 4.38e-67 | 1.11e+00 | 0.1153 |
10438 | C1D | P17T-E | Human | Esophagus | ESCC | 4.36e-13 | 6.02e-01 | 0.1278 |
10438 | C1D | P19T-E | Human | Esophagus | ESCC | 1.31e-20 | 1.19e+00 | 0.1662 |
10438 | C1D | P20T-E | Human | Esophagus | ESCC | 1.96e-39 | 8.34e-01 | 0.1124 |
10438 | C1D | P21T-E | Human | Esophagus | ESCC | 3.15e-51 | 9.34e-01 | 0.1617 |
10438 | C1D | P22T-E | Human | Esophagus | ESCC | 9.38e-62 | 1.09e+00 | 0.1236 |
10438 | C1D | P23T-E | Human | Esophagus | ESCC | 4.62e-38 | 1.04e+00 | 0.108 |
10438 | C1D | P24T-E | Human | Esophagus | ESCC | 1.13e-28 | 6.12e-01 | 0.1287 |
10438 | C1D | P26T-E | Human | Esophagus | ESCC | 1.58e-87 | 1.52e+00 | 0.1276 |
10438 | C1D | P27T-E | Human | Esophagus | ESCC | 6.63e-49 | 8.34e-01 | 0.1055 |
10438 | C1D | P28T-E | Human | Esophagus | ESCC | 2.55e-60 | 1.14e+00 | 0.1149 |
10438 | C1D | P30T-E | Human | Esophagus | ESCC | 9.84e-39 | 1.28e+00 | 0.137 |
10438 | C1D | P31T-E | Human | Esophagus | ESCC | 9.50e-55 | 8.10e-01 | 0.1251 |
10438 | C1D | P32T-E | Human | Esophagus | ESCC | 1.35e-48 | 8.85e-01 | 0.1666 |
10438 | C1D | P36T-E | Human | Esophagus | ESCC | 1.15e-30 | 1.01e+00 | 0.1187 |
10438 | C1D | P37T-E | Human | Esophagus | ESCC | 7.46e-36 | 7.65e-01 | 0.1371 |
10438 | C1D | P38T-E | Human | Esophagus | ESCC | 7.75e-10 | 4.44e-01 | 0.127 |
10438 | C1D | P39T-E | Human | Esophagus | ESCC | 1.15e-40 | 7.05e-01 | 0.0894 |
10438 | C1D | P40T-E | Human | Esophagus | ESCC | 1.11e-19 | 5.50e-01 | 0.109 |
Page: 1 2 3 4 5 6 7 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00430877 | Cervix | CC | regulation of GTPase activity | 79/2311 | 348/18723 | 4.21e-08 | 2.60e-06 | 79 |
GO:003166710 | Cervix | CC | response to nutrient levels | 92/2311 | 474/18723 | 5.80e-06 | 1.42e-04 | 92 |
GO:00425948 | Cervix | CC | response to starvation | 46/2311 | 197/18723 | 1.24e-05 | 2.59e-04 | 46 |
GO:00068987 | Cervix | CC | receptor-mediated endocytosis | 53/2311 | 244/18723 | 2.52e-05 | 4.29e-04 | 53 |
GO:00301008 | Cervix | CC | regulation of endocytosis | 47/2311 | 211/18723 | 3.65e-05 | 5.82e-04 | 47 |
GO:00458077 | Cervix | CC | positive regulation of endocytosis | 27/2311 | 100/18723 | 5.55e-05 | 8.10e-04 | 27 |
GO:00435476 | Cervix | CC | positive regulation of GTPase activity | 53/2311 | 255/18723 | 8.72e-05 | 1.16e-03 | 53 |
GO:00162367 | Cervix | CC | macroautophagy | 58/2311 | 291/18723 | 1.40e-04 | 1.70e-03 | 58 |
GO:00161977 | Cervix | CC | endosomal transport | 48/2311 | 230/18723 | 1.65e-04 | 1.97e-03 | 48 |
GO:00431127 | Cervix | CC | receptor metabolic process | 37/2311 | 166/18723 | 2.31e-04 | 2.58e-03 | 37 |
GO:00482597 | Cervix | CC | regulation of receptor-mediated endocytosis | 24/2311 | 110/18723 | 3.62e-03 | 2.31e-02 | 24 |
GO:00164827 | Cervix | CC | cytosolic transport | 33/2311 | 168/18723 | 4.43e-03 | 2.70e-02 | 33 |
GO:00316236 | Cervix | CC | receptor internalization | 24/2311 | 113/18723 | 5.18e-03 | 3.05e-02 | 24 |
GO:0009895 | Colorectum | AD | negative regulation of catabolic process | 124/3918 | 320/18723 | 1.66e-13 | 3.35e-11 | 124 |
GO:0031330 | Colorectum | AD | negative regulation of cellular catabolic process | 104/3918 | 262/18723 | 2.66e-12 | 3.96e-10 | 104 |
GO:0048193 | Colorectum | AD | Golgi vesicle transport | 109/3918 | 296/18723 | 1.80e-10 | 1.68e-08 | 109 |
GO:0016197 | Colorectum | AD | endosomal transport | 90/3918 | 230/18723 | 1.88e-10 | 1.73e-08 | 90 |
GO:0010506 | Colorectum | AD | regulation of autophagy | 111/3918 | 317/18723 | 3.57e-09 | 2.35e-07 | 111 |
GO:0016482 | Colorectum | AD | cytosolic transport | 68/3918 | 168/18723 | 6.00e-09 | 3.72e-07 | 68 |
GO:0016236 | Colorectum | AD | macroautophagy | 103/3918 | 291/18723 | 6.76e-09 | 4.15e-07 | 103 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0301810 | Esophagus | HGIN | RNA degradation | 27/1383 | 79/8465 | 7.73e-05 | 9.00e-04 | 7.15e-04 | 27 |
hsa0301815 | Esophagus | HGIN | RNA degradation | 27/1383 | 79/8465 | 7.73e-05 | 9.00e-04 | 7.15e-04 | 27 |
hsa03018 | Liver | Cirrhotic | RNA degradation | 44/2530 | 79/8465 | 1.43e-06 | 1.65e-05 | 1.02e-05 | 44 |
hsa030181 | Liver | Cirrhotic | RNA degradation | 44/2530 | 79/8465 | 1.43e-06 | 1.65e-05 | 1.02e-05 | 44 |
hsa030182 | Liver | HCC | RNA degradation | 58/4020 | 79/8465 | 2.29e-06 | 2.19e-05 | 1.22e-05 | 58 |
hsa030183 | Liver | HCC | RNA degradation | 58/4020 | 79/8465 | 2.29e-06 | 2.19e-05 | 1.22e-05 | 58 |
hsa030189 | Oral cavity | OSCC | RNA degradation | 59/3704 | 79/8465 | 2.05e-08 | 1.91e-07 | 9.70e-08 | 59 |
hsa0301814 | Oral cavity | OSCC | RNA degradation | 59/3704 | 79/8465 | 2.05e-08 | 1.91e-07 | 9.70e-08 | 59 |
hsa0301823 | Oral cavity | LP | RNA degradation | 39/2418 | 79/8465 | 6.98e-05 | 4.38e-04 | 2.83e-04 | 39 |
hsa0301833 | Oral cavity | LP | RNA degradation | 39/2418 | 79/8465 | 6.98e-05 | 4.38e-04 | 2.83e-04 | 39 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
C1D | SNV | Missense_Mutation | c.109T>C | p.Ser37Pro | p.S37P | Q13901 | protein_coding | deleterious(0.02) | possibly_damaging(0.798) | TCGA-AA-3510-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
C1D | SNV | Missense_Mutation | c.7N>A | p.Gly3Ser | p.G3S | Q13901 | protein_coding | tolerated(0.9) | benign(0) | TCGA-AZ-6607-01 | Colorectum | colon adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | PD | |
C1D | SNV | Missense_Mutation | c.32N>T | p.Pro11Leu | p.P11L | Q13901 | protein_coding | deleterious(0) | possibly_damaging(0.661) | TCGA-DM-A28F-01 | Colorectum | colon adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD | |
C1D | SNV | Missense_Mutation | novel | c.4N>A | p.Ala2Thr | p.A2T | Q13901 | protein_coding | deleterious(0.04) | probably_damaging(0.976) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
C1D | SNV | Missense_Mutation | c.192N>G | p.Asn64Lys | p.N64K | Q13901 | protein_coding | deleterious(0) | probably_damaging(0.927) | TCGA-AP-A0LM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD | |
C1D | SNV | Missense_Mutation | novel | c.305A>T | p.Asp102Val | p.D102V | Q13901 | protein_coding | deleterious(0) | benign(0.17) | TCGA-B5-A1MX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Hormone Therapy | megace | SD |
C1D | insertion | Frame_Shift_Ins | novel | c.222dupA | p.Gly75ArgfsTer3 | p.G75Rfs*3 | Q13901 | protein_coding | TCGA-B5-A1MX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Hormone Therapy | megace | SD | ||
C1D | insertion | Frame_Shift_Ins | rs776000138 | c.359_360insA | p.Asn120LysfsTer17 | p.N120Kfs*17 | Q13901 | protein_coding | TCGA-BK-A13B-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | PD | ||
C1D | SNV | Missense_Mutation | novel | c.403N>G | p.Asn135Asp | p.N135D | Q13901 | protein_coding | tolerated(0.3) | benign(0) | TCGA-L4-A4E5-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
C1D | SNV | Missense_Mutation | rs775915228 | c.27N>A | p.Asp9Glu | p.D9E | Q13901 | protein_coding | tolerated(0.37) | benign(0.017) | TCGA-CV-5979-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |